Read More Pharma Industry News Bristol Myers Squibb and 2seventy bio’s Abecma gets positive FDA committee vote for multiple myeloma In a significant development in the healthcare industry, Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq:… byPallavi MadhirajuMarch 18, 2024